Provider review
Midi Health review
A full dose-by-dose price table — with the lowest band priced flat.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
$165.90 per 4 weeks at 0.1–0.5 mg
Visit Midi HealthFour product lines, a milligram against every price, reaching to 0.075 mg sublingual. But 0.1, 0.25, 0.35 and 0.5 mg injectable all cost the same.
Price as published
Midi Health
$165.90 per 4 weeks at 0.1–0.5 mg
- Vs median
- Not comparable — billed per four weeks, which is thirteen charges a year rather than twelve, so it is not a monthly rate
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Quotes off the lowest dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Midi publishes the most granular price disclosure here: four product lines, injectable and sublingual, each with a dose-by-dose table carrying a milligram figure against every price, and every line stated as a four-week supply with shipping included. Its sublingual line reaches down to 0.075 mg, the lowest single published dose anywhere here. Across the ladder as a whole the price genuinely rises with the dose, which is what a low-dose reader wants. The qualification is where the ladder starts. The four lowest injectable rungs are all priced identically, so someone deliberately taking a fifth of that band's top dose pays exactly what its top dose costs — the ladder rewards staying below the next band, not taking the smallest amount you can. Two other things shape the real cost. A four-week supply is not a month, so it recurs about thirteen times a year rather than twelve. And the table prices medication only: it states that shipping and supplies are included and says nothing whatever about the clinical visit — the words consultation and visit fee appear nowhere on the pricing page — so the published figures are not the full cost of care, and what the rest comes to is not published where the prices are. Worth knowing what you are joining, too — this is a midlife women's clinic that prescribes GLP-1s, not a weight-management service.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want to see the dose and the price on the same row before committing, across every product and both routes
- You want the lowest published starting dose available here, which is on its sublingual line
- You want a needle-free route at a published price rather than as a consultation-only option
- You are seeking perimenopause or menopause care and want the GLP-1 handled inside it
Look elsewhere if
- You intend to take the very smallest injectable dose — the lowest four rungs cost the same, so going below the band's top dose buys you nothing
- You are budgeting monthly: prices are per four-week supply, which recurs about thirteen times a year
- You want the full cost of care in one figure — the table prices medication only and is silent on what the clinical visit costs
- You want a dedicated weight-management service rather than a broader midlife clinic
What it actually costs
Price as published
$165.90 per 4 weeks at 0.1–0.5 mg
- Vs median
- Not comparable — billed per four weeks, which is thirteen charges a year rather than twelve, so it is not a monthly rate
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Quotes off the lowest dose
States plainly that its advertised figures are based on the lowest dosage and that higher doses may cost more. On a general ranking that is a warning; for someone staying small it is the one model that bills accordingly.
49 of the 548 programs here price a small dose this way. Publishes a complete dose-by-dose price table for four product lines, with a milligram figure against every price and the price rising with the dose — the clearest version of this structure anywhere. The lowest injectable band is flat inside itself, 0.1 through 0.5 mg at one price, so you save by staying under the next band, not by taking the smallest possible amount.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Confirm any separate fee
- Dietitian
- Not confirmed
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- Publishes a complete dose-by-dose price table across four product lines, with a milligram figure against every price — the most granular disclosure of its kind here
- The sublingual line starts at 0.075 mg, the lowest single published dose here, for readers who want a genuinely small starting amount
- Prices rise with dose across the ladder as a whole, so a patient who stays in the lower bands pays materially less than one at the top
- Every figure is stated as a 4-week supply with shipping included, so the unit being priced is explicit rather than implied
- Offers a needle-free sublingual route at a published price rather than as a consultation-only option
Pharmacy, labs and oversight
Midi Health does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. Confirm whether clinician visits cost extra.
Transparency check
2 of 4 published openly
What Midi Health publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Midi Health is a women's midlife telehealth clinic — perimenopause and menopause care — that prescribes GLP-1s alongside its broader hormonal and metabolic services. Its pricing page is among the most complete here: it publishes a dose-by-dose table for four separate product lines (GLP-1 and dual-action GLP-1/GIP, each in injectable and sublingual form), with a milligram figure and a dollar figure on every row, each stated as a 4-week supply with shipping included. The sublingual line reaches down to 0.075 mg, the lowest published dose here.
The honest cons
Within the lowest injectable band the price is flat: 0.1 mg, 0.25 mg, 0.35 mg and 0.5 mg are all $165.90, so a patient deliberately taking a fifth of the band's top dose pays exactly what its top dose costs. The ladder rewards staying under 0.75 mg, not staying low
- A 4-week supply is not a month — billed every four weeks, that is 13.04 charges a year rather than 12, so the effective annual cost runs about 8.6% above what the figure implies
- The table prices MEDICATION only. It states that the prices include shipping and supplies and says nothing at all about the cost of the clinical visit — the words consultation and visit fee do not appear on the pricing page — so the published figures are not the whole cost of care and the remainder is not published here
- It is a midlife women's clinic rather than a weight-management service, so the GLP-1 sits inside a broader care model a reader may not want
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Midi Health is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs to compare with Midi Health. Both are partners: we may earn a commission if you start care through these links.
Partner
Sesame Care
Wegovy pill from $149/mo + sub
Standard plan, self-directed low dose
Partner
RxSpan MD
$249/mo month to month ($199 on 6-mo)
Standard plan, self-directed low dose
Where this sits
#81 of 548
Ordered with the companies that pay us first, and Midi Health is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- Oral semaglutide (Rybelsus)
- What microdosing GLP-1 costs
- The true annual cost of a plan
- Microdose & reconstitution calculator
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Another program to compare
Peter MD
$149/mo GLP1+B12 · $249/mo tirz (quarterly)
- Vs median
- $26/mo below the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Peter MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.